Literature DB >> 35428687

Sociodemographic characteristics and cervical cancer survival in different regions of the United States: a National Cancer Database study.

Michael D Toboni1,2, Alexander Cohen3,2, Zachary L Gentry2, Stuart A Ostby2, Zhixin Wang4, Sejong Bae4, Charles Leath2.   

Abstract

OBJECTIVE: To determine how sociodemographic factors impact cervical cancer survival in different geographic locations in the USA.
METHODS: A retrospective cohort of patients with cervical cancer from January 1, 2004 to December 31, 2015 in the National Cancer Database (NCDB) was identified. Tumor characteristics as well as race, income, insurance type, and treating facility types were compared among nine geographic regions. χ2 tests and Cox regression were used to compare differences between regions; p values <0.05 were considered significant.
RESULTS: A total of 48 787 patients were included. Survival was inferior in seven of nine regions for underinsured patients. In six regions survival was inferior for Medicaid and Medicare patients, respectively: Middle Atlantic: hazard ratio (HR) 1.25 and 1.22; South Atlantic: HR 1.41 and HR 1.22; East North Central: HR 1.36 and HR 1.25; East South Central: HR 1.37 and HR 1.25; West North Central: HR 1.67 and HR 1.42; West South Central: HR 1.44 and HR 1.46. In the Pacific region survival was inferior for Medicare patients (HR 1.35) but not inferior for Medicaid patients. Being uninsured was associated with worse survival in the South Atlantic (HR 1.23), East North Central (HR 1.23), East South Central (HR 1.56), and West South Central (HR 1.31) regions. Annual income level under $38 000 was associated with worse survival in the Middle Atlantic (HR 1.24), South Atlantic (HR 1.35), and East North Central (HR 1.49) regions. Lastly, when compared with academic research institutions, comprehensive community cancer centers had significantly worse survival in four of the nine regions.
CONCLUSIONS: Cervical cancer mortality is higher for women with a low income, underinsured (Medicaid or Medicare) or uninsured status, and decreased access to academic institutions in most US regions. An increase in cervical cancer mortality was associated with underinsured or uninsured populations in regions mainly located in the South and Midwest. © IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Cervical Cancer; Cervix Uteri

Mesh:

Year:  2022        PMID: 35428687      PMCID: PMC9177815          DOI: 10.1136/ijgc-2021-003227

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   4.661


  29 in total

1.  National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?

Authors:  Brandon A Mahal; Yu-Wei Chen; Vinayak Muralidhar; Amandeep R Mahal; Toni K Choueiri; Karen E Hoffman; Jim C Hu; Christopher J Sweeney; James B Yu; Felix Y Feng; Simon P Kim; Clair J Beard; Neil E Martin; Quoc-Dien Trinh; Paul L Nguyen
Journal:  Cancer       Date:  2016-07-19       Impact factor: 6.860

2.  ACOG Committee opinion no. 552: benefits to women of Medicaid expansion through the Affordable Care Act.

Authors: 
Journal:  Obstet Gynecol       Date:  2013-01       Impact factor: 7.661

3.  Geographic access to gynecologic cancer care in the United States.

Authors:  David I Shalowitz; Alexandra M Vinograd; Robert L Giuntoli
Journal:  Gynecol Oncol       Date:  2015-04-25       Impact factor: 5.482

4.  Racial and Ethnic Disparities in Health Insurance Coverage: Dynamics of Gaining and Losing Coverage over the Life-Course.

Authors:  Heeju Sohn
Journal:  Popul Res Policy Rev       Date:  2016-10-15

5.  Cancer statistics, 2022.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2022-01-12       Impact factor: 508.702

6.  Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.

Authors:  Michael T Halpern; Elizabeth M Ward; Alexandre L Pavluck; Nicole M Schrag; John Bian; Amy Y Chen
Journal:  Lancet Oncol       Date:  2008-02-20       Impact factor: 41.316

7.  Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.

Authors:  Emiko Petrosky; Joseph A Bocchini; Susan Hariri; Harrell Chesson; C Robinette Curtis; Mona Saraiya; Elizabeth R Unger; Lauri E Markowitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-03-27       Impact factor: 17.586

8.  Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States.

Authors:  Wonsuk Yoo; Sangmi Kim; Warner K Huh; Sarah Dilley; Steven S Coughlin; Edward E Partridge; Yunmi Chung; Vivian Dicks; Jae-Kwan Lee; Sejong Bae
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

9.  Impact of Medicaid expansion on women with gynecologic cancer: a difference-in-difference analysis.

Authors:  Benjamin B Albright; Dimitrios Nasioudis; Stuart Craig; Haley A Moss; Nawar A Latif; Emily M Ko; Ashley F Haggerty
Journal:  Am J Obstet Gynecol       Date:  2020-08-07       Impact factor: 8.661

10.  Has the Affordable Care Act Been Associated with Increased Insurance Coverage and Early-stage Diagnoses of Bone and Soft-tissue Sarcomas in Adults?

Authors:  Azeem Tariq Malik; John Alexander; Safdar N Khan; Thomas J Scharschmidt
Journal:  Clin Orthop Relat Res       Date:  2021-03-01       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.